Physician profile
Aaron D Richman
NPI 1093714156
$5,143.19
in general payments reported to CMS, 2019-2025
36 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,849 · 2020: $2,078 · 2021: $1,153 · 2022: $62.82.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $610.57 | 2019-2021 | |
| Glaxosmithkline, LLC. | $524.41 | 2019-2021 | |
| Abbvie INC. | $477.86 | 2019-2021 | |
| Allergan, INC. | $427.46 | 2019-2020 | |
| Novo Nordisk INC | $418.61 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $399.09 | 2019-2021 | |
| Lilly USA, LLC | $321.53 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $316.86 | 2019-2021 | |
| Amarin Pharma, INC. | $259.40 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $185.31 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $151.77 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $119.31 | 2019-2022 | |
| Daiichi Sankyo INC. | $101.79 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $80.36 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $79.00 | 2019-2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $77.97 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $68.27 | 2019-2021 | |
| Esperion Therapeutics, INC. | $64.05 | 2020 | |
| Ibsa Pharma INC. | $53.47 | 2019-2020 | |
| Strongbridge US INC. | $44.10 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $41.49 | 2020-2021 | |
| Astellas Pharma US INC | $34.34 | 2020-2021 | |
| Genentech USA, INC. | $33.75 | 2019-2020 | |
| Abbott Laboratories | $30.36 | 2019 | |
| Sanofi Pasteur INC. | $28.20 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $24.63 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $20.07 | 2021 | |
| Alfasigma USA, INC. | $19.81 | 2021 | |
| Avanir Pharmaceuticals, INC. | $19.68 | 2019 | |
| Mannkind Corporation | $19.51 | 2019 | |
| Jazz Pharmaceuticals INC. | $19.18 | 2019 | |
| Circassia INC. | $16.95 | 2020 | |
| Ironwood Pharmaceuticals, INC | $15.36 | 2020 | |
| Sanofi-Aventis U.S. LLC | $13.57 | 2020 | |
| Medtronic Minimed, INC. | $12.72 | 2020 | |
| Metuchen Pharmaceuticals | $12.38 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Richman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.